Drospirenone 3mg + Ethinylestradiol 0.02mg Tablet in PCD pharma franchise in Hyderabad

Drospirenone 3mg + Ethinylestradiol 0.02mg Tablet in pharmaceutical manufacturing company in Mumbai

Drospirenone 3mg + Ethinylestradiol 0.02mg Tablet in hormonal care pharma franchise in Pune

Drospirenone 3mg + Ethinylestradiol 0.02mg Tablet in pharma suppliers in Delhi

Drospirenone 3mg + Ethinylestradiol 0.02mg Tablet in pharma export companies in Kolkata
Drospirenone 3mg + Ethinylestradiol 0.02mg Tablet in pharma franchise opportunities in Bengaluru

Home/Products /drospirenone-3-mg-ethinylestradiol-0-point-02-mg-tablet

Smilepill 30 Tablet

Composition : Drospirenone 3 mg + Ethinylestradiol 0.02 mg Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10x1x21

Price : ₹1/-

This tablet combines Drospirenone (3 mg), a progestin, and Ethinylestradiol (0.02 mg), a synthetic estrogen, to form a low-dose oral contraceptive. It works by preventing ovulation, altering the cervical mucus to block sperm entry, and changing the endometrial lining to prevent implantation. Beyond contraception, this combination also helps regulate menstrual cycles, reduce menstrual cramps, treat acne, and manage premenstrual symptoms.


Read More

About the Product

This tablet combines Drospirenone (3 mg), a progestin, and Ethinylestradiol (0.02 mg), a synthetic estrogen, to form a low-dose oral contraceptive. It works by preventing ovulation, altering the cervical mucus to block sperm entry, and changing the endometrial lining to prevent implantation. Beyond contraception, this combination also helps regulate menstrual cycles, reduce menstrual cramps, treat acne, and manage premenstrual symptoms.


Mild side effects may include nausea, headache, breast tenderness, mood changes, or weight fluctuation. Rare but serious effects include blood clots, hypertension, or liver issues. Regular monitoring is advised for long-term users.

Primarily indicated for oral contraception to prevent pregnancy. It is also used in the treatment of acne vulgaris, premenstrual dysphoric disorder (PMDD), menstrual irregularities, and hormonal imbalance-related symptoms in women of reproductive age.

This medication should only be used under medical supervision. It is contraindicated in women with a history of thromboembolic disorders, liver disease, breast cancer, or uncontrolled hypertension. Smoking increases the risk of cardiovascular side effects, especially in women over 35. Not intended for use during pregnancy.

Store at room temperature (15-30°C), away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation